Valuation: Orthofix International NV

Market Cap 378M 332M 305M 285M 537M 35.93B 548M 3.67B 1.42B 17.64B 1.42B 1.39B 61.38B P/E 2026 *
-7.7x
P/E 2027 * -9.26x
Enterprise Value 378M 332M 305M 285M 537M 35.93B 548M 3.67B 1.42B 17.64B 1.42B 1.39B 61.38B EV / Sales 2026 *
0.45x
EV / Sales 2027 * 0.43x
Free-Float
97.81%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 54 08/01/2024
Director of Finance/CFO 55 15/01/2024
Compliance Officer - 01/02/2015
Director TitleAgeSince
Director/Board Member 66 16/03/2016
Director/Board Member 54 08/06/2020
Director/Board Member 64 05/01/2023
Change 5-day change 1-year change 3-year change Capi.($)
+1.33%+0.91% - - 378M
+1.65%-0.20%-30.62%-13.22% 161B
+2.22%-0.17%-8.95%-7.76% 101B
+1.84%+2.09%+0.61%+53.44% 56.12B
-1.22%-2.03%+54.34%+47.88% 53.35B
+1.50%+1.95%-12.94%-41.08% 42.13B
+1.63%+11.31% - - 35.29B
+2.70%+2.20%-16.06%-44.76% 26.57B
+0.25%+5.87%+65.86%-3.02% 25.79B
+0.80%+1.54%-10.25%-2.42% 20.69B
Average +1.17%+3.11%+5.25%-1.37% 57.99B
Weighted average by Cap. +1.31%+2.01%-4.88%-0.83%

Financials

2026 *2027 *
Net sales 841M 739M 680M 634M 1.19B 79.99B 1.22B 8.18B 3.17B 39.26B 3.16B 3.09B 137B 881M 774M 712M 664M 1.25B 83.8B 1.28B 8.57B 3.32B 41.14B 3.31B 3.24B 143B
Net income -47.49M -41.7M -38.38M -35.76M -67.45M -4.51B -68.82M -462M -179M -2.22B -178M -174M -7.71B -40.38M -35.45M -32.63M -30.41M -57.35M -3.84B -58.51M -392M -152M -1.88B -152M -148M -6.56B
Net Debt - -
Logo Orthofix International NV
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-